Cheff DM, Cheng Q, Guo H, Travers J, Klumpp-Thomas C, Shen M, et al
Your prescriber should document the clinical rationale for selecting Saxenda over alternatives, as insurance companies may require step therapy (trying a preferred agent first) before approving Saxenda
By the following morning after normal hydration and activity, the scale is back to where it was
References ScienceDirect Bremelanotide: pharmacology, toxicology, and therapeutic overview (active metabolite of Melanotan II) FDA Vyleesi (bremelanotide) prescribing information
NICE guidelines recommend lifestyle modifications as foundational therapy, but many patients require additional pharmacological treatment to achieve glycaemic targets or clinically significant weight loss